Interstitial Pneumonia is a large group of diseases, the severity of which is closely related to the specific type of disease. Although most interstitial pneumonias are incurable and the fibrotic scarring of the lungs that results from the disease is difficult to eliminate, patients who receive timely and standardized treatment can have their quality of life and survival effectively improved. However, idiopathic fibrosis in interstitial pneumonia has a poorer prognosis. Interstitial pneumonia is a respiratory disease caused by inflammatory and fibrotic lesions in the interstitium of the lungs due to various causes. If the patient does not receive timely treatment, the further development of the disease will lead to the formation of extensive interstitial fibrosis in the lungs, and the normal respiratory function of the lungs will be directly affected, causing respiratory distress, affecting the patient’s quality of life, and may even lead to respiratory failure, resulting in life-threatening conditions for the patient. Although lung fibrosis caused by interstitial pneumonia cannot be reversed, if patients follow the doctor’s instructions to implement appropriate treatment programs, then it can effectively reduce the inflammatory response, stop or reduce the progression of pulmonary fibrosis, to achieve the purpose of improving the quality of life and prolonging the survival period. However, the prognosis for idiopathic fibrosis in interstitial pneumonia is poor. Individuals with unexplained dyspnea and dry cough are advised to seek medical attention.